137 related articles for article (PubMed ID: 8722417)
1. Experimental radioimmunotherapy: biological effectiveness and comparison with external beam radiation.
Buchsbaum DJ; Roberson PL
Recent Results Cancer Res; 1996; 141():9-18. PubMed ID: 8722417
[No Abstract] [Full Text] [Related]
2. Comparison of radioimmunotherapy and external beam radiotherapy in colon cancer xenografts.
Buras RR; Wong JY; Kuhn JA; Beatty BG; Williams LE; Wanek PM; Beatty JD
Int J Radiat Oncol Biol Phys; 1993 Feb; 25(3):473-9. PubMed ID: 8436526
[TBL] [Abstract][Full Text] [Related]
3. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
4. Quantitative comparison of radiolabeled antibody therapy and external beam radiotherapy in the treatment of human glioma xenografts.
Williams JA; Edwards JA; Dillehay LE
Int J Radiat Oncol Biol Phys; 1992; 24(1):111-7. PubMed ID: 1512146
[TBL] [Abstract][Full Text] [Related]
5. Reconciliation of tumor dose response to external beam radiotherapy versus radioimmunotherapy with 131iodine-labeled antibody for a colon cancer model.
Roberson PL; Buchsbaum DJ
Cancer Res; 1995 Dec; 55(23 Suppl):5811s-5816s. PubMed ID: 7493351
[TBL] [Abstract][Full Text] [Related]
6. The treatment of patients with recurrent malignant gliomas with intratumoral radioimmunoconjugates.
Hopkins K; Papanastassiou V; Kemshead JT
Recent Results Cancer Res; 1996; 141():159-75. PubMed ID: 8722426
[No Abstract] [Full Text] [Related]
7. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
[TBL] [Abstract][Full Text] [Related]
8. Current status of radioimmunoglobulins in the treatment of human malignancy.
Order SE; Sleeper AM; Stillwagon GB; Klein JL; Leichner PK
Oncology (Williston Park); 1989 May; 3(5):115-20; discussion 122, 129-30. PubMed ID: 2577880
[TBL] [Abstract][Full Text] [Related]
9. Experimental radioimmunotherapy.
Buchsbaum DJ; Langmuir VK; Wessels BW
Med Phys; 1993; 20(2 Pt 2):551-67. PubMed ID: 8492764
[TBL] [Abstract][Full Text] [Related]
10. Prediction of tumor response to experimental radioimmunotherapy with 90Y in nude mice.
Dillehay LE; Mayer R; Zhang YG; Shao Y; Song SY; Mackensen DG; Williams JR
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):417-27. PubMed ID: 7673029
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric analysis of 177Lu-cG250 radioimmunotherapy in renal cell carcinoma patients: correlation with myelotoxicity and pretherapeutic absorbed dose predictions based on 111In-cG250 imaging.
Stillebroer AB; Zegers CM; Boerman OC; Oosterwijk E; Mulders PF; O'Donoghue JA; Visser EP; Oyen WJ
J Nucl Med; 2012 Jan; 53(1):82-9. PubMed ID: 22159179
[TBL] [Abstract][Full Text] [Related]
12. Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated α-Radioimmunotherapy with
Bäck T; Chouin N; Lindegren S; Kahu H; Jensen H; Albertsson P; Palm S
J Nucl Med; 2017 Apr; 58(4):598-604. PubMed ID: 27688477
[TBL] [Abstract][Full Text] [Related]
13. [The treatment of colonic and ovarian cancer with radioactive monoclonal antibodies against the CA l9-9 and CA 125 antigens].
Graef A; Romero MA; González M; Pierzo JA; Sosa R; Altamirano P
Gac Med Mex; 1992; 128(2):91-5. PubMed ID: 1302216
[TBL] [Abstract][Full Text] [Related]
14. The current status of targeted radiotherapy in clinical practice.
Gaze MN
Phys Med Biol; 1996 Oct; 41(10):1895-903. PubMed ID: 8912369
[TBL] [Abstract][Full Text] [Related]
15. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
16. Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude mice.
Buchegger F; Rojas A; Delaloye AB; Vogel CA; Mirimanoff RO; Coucke P; Sun LQ; Raimondi S; Denekamp J; Pèlgrin A
Cancer Res; 1995 Jan; 55(1):83-9. PubMed ID: 7805046
[TBL] [Abstract][Full Text] [Related]
17. Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects.
McLendon RE; Akabani G; Friedman HS; Reardon DA; Cleveland L; Cokgor I; Herndon JE; Wikstrand C; Boulton ST; Friedman AH; Bigner DD; Zalutsky MR
Nucl Med Biol; 2007 May; 34(4):405-13. PubMed ID: 17499730
[TBL] [Abstract][Full Text] [Related]
18. 131I radioimmunotherapy and fractionated external beam radiotherapy: comparative effectiveness in a human tumor xenograft.
Barendswaard EC; O'Donoghue JA; Larson SM; Tschmelitsch J; Welt S; Finn RD; Humm JL
J Nucl Med; 1999 Oct; 40(10):1764-8. PubMed ID: 10520720
[TBL] [Abstract][Full Text] [Related]
19. Timing effects of combined radioimmunotherapy and radiotherapy on a human solid tumor in nude mice.
Sun LQ; Vogel CA; Mirimanoff RO; Coucke P; Slosman DO; Mach JP; Buchegger F
Cancer Res; 1997 Apr; 57(7):1312-9. PubMed ID: 9102219
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle alterations, apoptosis, and response to low-dose-rate radioimmunotherapy in lymphoma cells.
Macklis RM; Beresford BA; Palayoor S; Sweeney S; Humm JL
Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):643-50. PubMed ID: 8226159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]